What is the treatment of cerebral vasospasm?
Nimodipine has been recommended as first-line medical treatment for preventing post-aSAH cerebral vasospasm. It is usually given orally at a dosage of 60 mg every 4 hours for 21 days after the initial subarachnoid hemorrhage.
What is gold standard for cerebral vasospasm?
Introduction: Cerebral vasospasm (CV) is one of the most dreaded complications in patients who survive acute subarachnoid haemorrhage (SAH), and conventional cerebral angiography (DSA) is the gold standard for its diagnosis.
What is Triple H therapy?
Hyperdynamic therapy, also called triple-H therapy, is the standard treatment and prophylaxis for aneurysmal-associated vasospasm. In patients who are able to tolerate cardiopulmonary stressors induced by this therapy, it is of benefit as a modality for prevention and treatment of delayed ischemic neurologic deficit.
When do you start taking nimodipine for SAH?
Nimodipine should start as early as possible or within 96 hours of the diagnosis of subarachnoid hemorrhage. Nimodipine is usually available as capsules of 30 mg. 1It has to be given at least 1 hour before or 2 hours after meals.
Why is nimodipine used for SAH?
Nimodipine is used to decrease problems due to a certain type of bleeding in the brain (subarachnoid hemorrhage-SAH). Nimodipine is called a calcium channel blocker. The body naturally responds to bleeding by narrowing the blood vessel to slow blood flow.
What can exacerbate cerebral vasospasm?
The iatrogenic factors that can increase the risk of cerebral vasospasm include prolongation of the subarachnoid clot by antifibrinolytic drugs, hypotension, inappropriate treatment of hyponatremia, hypovolemia, hyperthermia and increased intracranial pressure.
What is a normal Lindegaard ratio?
A Lindegaard ratio of 3–6 is indicative of mild to moderate vasospasm, and a ratio greater than 6.0 is indicative of severe vasospasm (Fig 10). Elevated flow velocities with a Lindegaard ratio of less than 3.0 are suggestive of hyperemia or another physiologic or induced state (1,6,12).
When should nimodipine be started in SAH?
Can mannitol be given in SAH?
There are theoretical benefits of giving mannitol to patients with SAH as it has been shown to reduce intracranial pressure and may act as a radical scavenger, decreasing ischaemic injury. There are also known side effects such as cardiopulmonary oedema and rebound cerebral oedema.
What are the treatment options for cerebral vasospasm (CV)?
Proactive and preventive strategies such as oral nimodipine and endovascular rescue therapies can reduce the morbidity and mortality associated with CV. A Review of the Management of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage
Is cerebral vasospasm still relevant in patients with subarachnoid hemorrhage?
Abstract Background: Despite decades of research, cerebral vasospasm (CV) continues to account for high morbidity and mortality in patients who survive their initial aneurysmal subarachnoid hemorrhage.
What is the pathogenesis of cerebral vasospasm and cerebral ischemia?
Progression to cerebral ischemia is tied mostly to vasospasm severity, and its pathogenesis lies in artery encasement by blood clot, although the complex interactions between … Cerebral Vasospasm: A Review
Can the delayed onset of vasospasm be prevented?
The delayed onset of vasospasm provides a potential opportunity for its prevention. It is disappointing that recent randomized, controlled trials did not demonstrate that the endothelin antagonist clazosentan, the cholesterol-lowering agent simvastatin, and the vasodilator magnesium sulfate improve patient outcome.